Skip to main content

Table 1 Baseline patient demographics (mean ± SD).

From: Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations

Variable

Patients

n = 203

Controls

n = 51

P Value

Female/Male (male %)

36/167 (82)

30/21 (41)

< 0.05

Age at Baseline

64.7 ± 7.8

59.5 ± 7.5

< 0.05

Number of Pack Years

28.7 ± 26.0

6.1 ± 13.6

< 0.05

Current smoker (%)

67 (33)

7 (14)

< 0.05

Former smoker (%)

84 (41)

10 (20)

< 0.05

Never smoker (%)

52 (26)

34 (66)

< 0.05

BMI (kg/m2) Derived

22.9 ± 3.2

24.0 ± 3.2

 

FEV1 (L)

1.78 ± 0.70

2.28 ± 0.57

< 0.05

FEV 1 Post (L)

1.90 ± 0.70

2.28 ± 0.60

< 0.05

FEV1/FVC (%)

61.6 ± 16.2

79.9 ± 5.0

< 0.05

FRC (L)

3.96 ± 1.38

3.03 ± 0.75

< 0.05

FVC (L)

3.00 ± 0.78

3.00 ± 0.80

 

FVC Post (L)

3.06 ± 0.74

3.00 ± 0.78

 

IC (L)

2.19 ± 0.58

2.24 ± 0.56

 

RV (L)

3.25 ± 1.68

2.23 ± 0.50

< 0.05

TLC (L)

6.14 ± 1.39

5.25 ± 1.06

< 0.05

DLCO (mmol/ kPa x min)

19.26 ± 5.61

22.86 ± 4.46

< 0.05